NCT07467629 2026-03-12
QLS5212 for Participants With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
Clinical Trials
6 trialsNCT07441174 2026-02-27
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Recruiting
NCT07257497 2025-12-02
Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol
West China Hospital
Phase 1 Not yet recruiting
NCT07117461 2025-10-16
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07046780 2025-07-02
A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06962254 2025-05-08
Imatinib and Trametinib for KRAS-mutated Solid Tumor
China Medical University Hospital
Phase 1 Recruiting